Mammographic Breast Density and Risk Factors of Breast Cancer in Korean Women Using Multicenter Study

다기관 연구를 통해 살펴본 한국여성에서 유방밀도와 유방암 위험요인

Cho, Jung-Jin;Song, Hong-Ji;Koh, En-Young;Song, Yun-Mi;Han, Bu-Kyung;Yun, Young-Sook;Park, Hyun-Ah;Lee, Sung-Hee;Yang, Jeong-Hee;Han, Heon;Seo, Young-Ran
조정진;송홍지;고은영;송윤미;한부경;윤영숙;박현아;이성희;양정희;한헌;서영란

  • Published : 20060100

Abstract

Background: Density patterns on mammography have been related to the risk factors for breast cancer in the western countries. High mammographic density appears to confer a 4-fold risk of breast cancer. While the proportion of high-density mammography is higher in Korean women than in Caucasian women, the incidence of breast cancer in Korean women is considerably lower. Therefore, we examined if the mammographic breast density pattern correlates with the risk factors for breast cancer in Korean women. Methods: In a cross-sectional design, we recruited 1,758 pre- and post-menopause women without prior history of breast cancer and breast surgery who underwent screening mammogram and completed a self-administered questionnaire in 6 general hospitals. On the basis of ACR BI RADS breast composition, four density patterns were classified in caudocranial and mediolateral mammography by a designated radiologist in each hospital. Multiple linear logistic regression was used for statistical analyses. Results: Inter-rater reliability between the initial report and the report made by another blinded radiologist was high (Pearson's co-efficient=0.81). Overall, the age, body mass index, family history of breast cancer, and duration of hormone replacement therapy correlated with the mammographic density patterns. In pre-menopausal women, the high body mass index and parity (=2) were associated with low mammographic density. In post- menopausal women, older age, high body mass index, negative family history of breast cancer, and duration of hormone replacement therapy were associated with low mammographic density. Conclusion: Our data showed that the mammographic breast density patterns correlated with risk factors for breast cancer in Korean women. While the proportion of high-density mammography is higher in Korean women, the incidence of breast cancer is lower than in the western population. This maybe dependent on other unknown factors.

연구배경: 서구에서 유방밀도는 유방암 위험요인과 관련성이 높을 뿐만 아니라 유방밀도가 유방암의 독립적인 위험요인이라고 한다. 그런데 한국 여성은 서구여성에 비해 고밀도 유방비율이 높은데도 불구하고 유방암 비율은 낮다. 따라서 일차적으로 한국여성에서 유방밀도와 유방암 위험요인과의 관련성이 서구와 차이가 있는지 살펴보는 것이 필요하다. 방법: 2002년 2월부터 8월까지 서울, 경기, 강원 지역 6개의 병원에서 유방암 선별검사로 유방촬영술을 받고 이전에 유방암, 유방수술의 병력이 없는 1,758명을 대상으로 유방암 위험요인에 대한 자기기입식 설문조사를 실시하였다. 유방촬영 판독은 해당 병원 방사선과 전문의 1인이 설문에 대한 정보 없이 유방촬영술 판독규약(ACR BI RADS)에 따라 유방밀도를 분류하였으며 병원별 판독자간의 오차를 평가하기 위해 각 병원별 6개씩 유방촬영사진을 수거하여 다른 방사선과 전문의에게 재판독하였다. 결과: 유방밀도에 대한 판독자간의 신뢰도는 높았다(Pearson's co-efficient=0.81). 유방밀도를 BI RAD 3, 4형인 고밀도 유방과 1, 2형인 저밀도 유방으로 나누어 다변량 분석을 해보면 연령이 낮을수록, 체질량지수가 낮을수록, 유방암 가족력이 있는 경우, 호르몬 대체 요법기간이 길수록 유의하게 유방 밀도가 높은 것으로 나타났다. 폐경 전후로 나누어 분석해보면 폐경 전에는 체질량지수가 높을수록 출산횟수가 2회인 경우 유의하게 유방밀도가 낮았다. 폐경 후에는 연령이 높을수록, 체질량지수가 높을수록, 유방암 가족력이 없는 경우, 호르몬 대체 요법기간이 짧을수록 유방밀도가 유의하게 낮았다. 결론: 한국 여성에서도 서구와 유사하게 유방암 위험요인들과 유방밀도와의 관련성이 있으며 특히 유방암가족력이 있는 경우 폐경 후에도 유방밀도가 계속 높은 것으로 나타났다. 한국에서 유방밀도가 높은데도 유방암 발생률이 낮은 것은 유방밀도와 유방암 위험요인과의 관련성 차이가 아닌 다른 요인에 의한 것일 가능성이 높음을 시사한다.

Keywords

References

  1. 유방암. 대한가정의학회편, 한국인의 평생건강관리. 개정판. 서울:계측문화사;2003. p.71-9
  2. 유근영, 노동영, 이은숙. 유방암의 조기 검진. 대한의사협회지 2002;45(8):992-1004
  3. 통계청. 2001년 사망원인 통계. 2001
  4. 국립암센터. 2001년 한국중앙암등록 사업 결과. 2001
  5. 김승형, 김미혜, 오기근. 유방촬영술상 연령에 따른 한국여성의 유방밀도 분석과 서양여성과의 비교. 대한방사선의학회지 2000;42:1009-14
  6. Carney PA, Miglioretti DL, Yankaskas BC, Kerlikowske K, Rosenberg R, Rutter CM, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003;138(3):168-75 https://doi.org/10.7326/0003-4819-138-3-200302040-00008
  7. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996;276(1): 33-8 https://doi.org/10.1001/jama.276.1.33
  8. Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7(12):1133-44
  9. Boyd NF, Martin MJ, Stone J, Greenberg C, Minkin S, Yaffe MJ. Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention. Curr Oncol Rep 2001;3(4):314-21 https://doi.org/10.1007/s11912-001-0083-7
  10. American college of Radiology (ACR) Illustrated Breast Imaging Reporting and Data System (BI-RADSTM). 3rd ed. Reston, Va: American College of Radiology; 1998
  11. Grove JS, Goodman MJ, Gilbert FI Jr, Mi MF. Factors associated with mammographic pattern. Br J Radiol 1985;58:21-5 https://doi.org/10.1259/0007-1285-58-685-21
  12. Grove JS, Goodman MJ, Gilbert FI, Clyde D. Factors associated with breast structures in breast cancer patients. Cancer 1979;43:1895-9 https://doi.org/10.1002/1097-0142(197905)43:5<1895::AID-CNCR2820430546>3.0.CO;2-R
  13. Wolfe JN. Breast parenchymal patterns and their changes with age. Radiology 1976;121:545-52 https://doi.org/10.1148/121.3.545
  14. Stomper PC, D'Souza DJ, DiNitto PA, Arredondo MA, Analysis of parenchymal density on mammograms in 1353 women 25-79 years old. AJR Am J Roentgenol 1996;167(5):1261-5 https://doi.org/10.2214/ajr.167.5.8911192
  15. Brisson J, Morrison AS, Kopans DB, Sadowsky NL, Kalisher L, Twaddle JA, et al. Height and weight, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 1984; 119:371-81 https://doi.org/10.1093/oxfordjournals.aje.a113755
  16. Maskarinec G, Meng L, Ursin G. Ethnic differences in mammographic densities. Int J Epidemiol 2001;30(5):959-65 https://doi.org/10.1093/ije/30.5.959
  17. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993;15(1):36-47 https://doi.org/10.1093/oxfordjournals.epirev.a036115
  18. de Waard F, Rombach JJ, Collette HJ, Slotboom B. Breast cancer risk associated with reproductive factors and breast parenchymal patterns. J Natl Cancer Inst 1984;72:1277-82
  19. Whitehead J, Carlile T, Kopecky KJ, Thompson DJ, Gilbert FI Jr, Present AJ, et al. The relationship between Wolfe's classification of mammograms, accepted breast cancer risk factors, and the incidence of breast cancer. Am J Epidemiol 1985;122:994-1006 https://doi.org/10.1093/oxfordjournals.aje.a114203
  20. Boyd NF, O'Sullivan B, Campbell JE, Fishell E, Sinor I, Cooke G, et al. Mammographic signs as risk factors for breast cancer. Br J Cancer 1982;45:185-93 https://doi.org/10.1038/bjc.1982.32
  21. Brisson J, Sadowsky NL, Twaddle JA, Morrison AS, Cole P, et al. Mammographic features of the breast and breast cancer risk. Am J Epidemiol 1982;115:428-37 https://doi.org/10.1093/oxfordjournals.aje.a113320
  22. Brisson J, Verreault R, Morrison AS, Tennina S, Meyer F. Diet, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 1989;130:14-24 https://doi.org/10.1093/oxfordjournals.aje.a115305
  23. Wolfe JN, Saftlas AF, Salane M. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. AJR Am J Roentgenol 1987;148: 1087-92 https://doi.org/10.2214/ajr.148.6.1087
  24. Saftlas AF, Hoover RN, Brinton LA, Szklo M, Olson DR, Salane M, et al. Mammographic densities and risk of breast cancer. Cancer 1991;67:2833-8 https://doi.org/10.1002/1097-0142(19910601)67:11<2833::AID-CNCR2820671121>3.0.CO;2-U
  25. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995;87:670-5 https://doi.org/10.1093/jnci/87.9.670
  26. Kato I, Beinart C, Bleich A, Su S, Kim M, Toniolo PG. A nested case-control study of mammographic patterns, breast volume, and breast cancer (New York City, NY, United States). Cancer Causes Contol 1995;6:431-8 https://doi.org/10.1007/BF00052183
  27. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 1995;87:1622-9 https://doi.org/10.1093/jnci/87.21.1622
  28. Dupont WD, Page DL. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med. 1991;151(1):67-72 https://doi.org/10.1001/archinte.151.1.67
  29. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350(9084):1047-59 https://doi.org/10.1016/S0140-6736(97)08233-0
  30. Porch JV, Lee IM, Cook NR, Rexrode KM, Burin JE. Estrogenprogestin replacement therapy and breast cancer risk: the Women's Health Study (United States). Cancer Causes Control 2002;13(9):847-54 https://doi.org/10.1023/A:1020617415381
  31. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280(7): 605-13 https://doi.org/10.1001/jama.280.7.605
  32. Persson I, Thurfjell E, holmberg L. Effect of estrogen and estrogen-progestin replacement regiemens on mammographic breast parnechimal density. J Clin Oncol 1997;15:3201-7 https://doi.org/10.1200/JCO.1997.15.10.3201
  33. Maskarinec G, Nagata C, Shimizu H, Kashiki Y. Comparison of mammographic ensities and their determinants in women from Japan and Hawaii. Int J Cancer 2002;102(1):29-33 https://doi.org/10.1002/ijc.10673